Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
ASSETS
Current assets:
Cash and cash equivalents
Total cash and cash equivalents
Short-term investments
Accounts receivable, less allowances of $55 and $66, respectively
Total accounts receivable, less allowances of $55 and $66, respectively
Prepaid expenses
Total prepaid expenses
Income taxes and other current assets
Total income taxes and other current assets
Total current assets
Property, plant and equipment, net
Total property, plant and equipment, net
Other intangibles, net
Total other intangibles, net
Other assets
Total other assets
Total assets
LIABILITIES AND EQUITY
Current liabilities:
Long-term debt due within one year
Total long-term debt due within one year
Accounts payable
Total accounts payable
Accounts payable and accrued liabilities
Advanced billings
Total advanced billings
Accrued other taxes
Total accrued other taxes
Accrued interest
Total accrued interest
Pension and other postretirement benefits
Total pension and other postretirement benefits
Other current liabilities
Total other current liabilities
Total current liabilities
Deferred income taxes
Total deferred income taxes
Pension and other postretirement benefits
Total pension and other postretirement benefits
Other liabilities
Total other liabilities
Long-term debt
Total long-term debt
Liabilities
Total liabilities
Equity:
Common stock, $0.01 par value (1,750,000 authorized shares, 250,336 and 249,695 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively)
Total common stock, $0.01 par value (1,750,000 authorized shares, 250,336 and 249,695 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively)
Additional paid-in capital
Total additional paid-in capital
Retained earnings
Total retained earnings
Accumulated other comprehensive income, net of tax
Total accumulated other comprehensive income, net of tax
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support